NEW YORK (GenomeWeb News) – Kreatech Diagnostics will partner with Semmelweis University in Budapest, Hungary, to develop new biosample handling methods for use with microarrays.
The company said on Thursday that it will work with the University's 1st Department of Pathology and Experimental Cancer Research to co-develop new micromethods for handling limited amounts of biological samples for microarray analysis.
Amsterdam-based Kreatech said that it will develop a specific methodology that will work with its Universal Linkage System and will be used for processing very limited amounts of formalin-fixed paraffin-embedded samples for array comparative genomic hybridization.
The micromethods will be used in biopsies, laser capture of microdissected cells, and fine needle aspiration.
Also under the partnership, Semmelweiss, which has a large tissue repository, will define putative biomarkers for certain tumor types, and Kreatech will develop and manufacture the corresponding DNA probes for in situ hybridization.